TIMI 31
TIMI 31 evaluated the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST-elevation myocardial infarction.
Key Study Publications
Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.